{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:08:29Z","timestamp":1793304509455,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH123724"],"award-info":[{"award-number":["R01 MH123724"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH123724"],"award-info":[{"award-number":["R01 MH123724"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH123724"],"award-info":[{"award-number":["R01 MH123724"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH123724"],"award-info":[{"award-number":["R01 MH123724"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y004094\/1"],"award-info":[{"award-number":["MR\/Y004094\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y004094\/1"],"award-info":[{"award-number":["MR\/Y004094\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["D0886501"],"award-info":[{"award-number":["D0886501"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>More than 20% of individuals with schizophrenia show minimal or no response to antipsychotic medications and little is known about genetic contributions to more severe forms of illness. This study sought to explore if cases with continuously-hospitalized, treatment-resistant schizophrenia (CH-TRS) carry a higher burden of common genetic variants compared to less severe forms. CH-TRS cases were recruited from Pennsylvania state psychiatric hospitals in the USA, with\u2009\u2265\u20095 years of continuous hospitalization, active treatment, and non-response to\u2009\u2265\u20093 antipsychotic medications. Three comparator groups were obtained from cohorts in the USA, Sweden, and the UK including TRS, general schizophrenia and non-psychiatric controls. Polygenic scores (PGS) of schizophrenia and cognitive ability were generated in individuals of European and African ancestry. Logistic regression assessed the association of PGS and CH-TRS cases (vs. comparators), with sex differences and sensitivity analyses excluding individuals with other diagnoses conducted to assess robustness. We included 18,571 individuals of European ancestry (346 CH-TRS, 10,757 TRS, 1148 general schizophrenia, 6320 non-psychiatric controls) and exploratory analyses of 476 individuals of African ancestry (78 CH-TRS, 398 non-psychiatric controls). For each standard deviation increase in the schizophrenia PGS, the odds of CH-TRS among individuals of European ancestry increased by 40\u201380% compared to general schizophrenia and TRS. Results in African ancestry participants mirrored those of European ancestry albeit with reduced levels of significance. Sex interactions and sensitivity analyses did not materially alter the estimates. This study demonstrates a greater burden of common genetic variants is associated with more severe forms of illness in schizophrenia.<\/jats:p>","DOI":"10.1038\/s41380-026-03806-x","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:20:10Z","timestamp":1785842410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The association of schizophrenia polygenic scores with continuously-hospitalized, treatment-resistant schizophrenia"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7639-6521","authenticated-orcid":false,"given":"Urmi","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-1557","authenticated-orcid":false,"given":"James J.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-2587","authenticated-orcid":false,"given":"Robert","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-3654","authenticated-orcid":false,"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7073-2379","authenticated-orcid":false,"given":"Michael","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6980-4053","authenticated-orcid":false,"given":"James T. R.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Didriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Josiassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3928-9879","authenticated-orcid":false,"given":"Kaarina","family":"Kowalec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"3806_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/15622970510030090","volume":"6","author":"P Falkai","year":"2005","unstructured":"Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, M\u00f6ller H-J, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: acute treatment of schizophrenia. World J Biol Psychiatry. 2005;6:132\u201391.","journal-title":"World J Biol Psychiatry"},{"key":"3806_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373:31\u201341.","journal-title":"Lancet"},{"key":"3806_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","volume":"174","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJM, Birnbaum ML, et al. Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 2017;174:216\u201329.","journal-title":"Am J Psychiatry"},{"key":"3806_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.psychres.2013.06.042","volume":"210","author":"A de Bartolomeis","year":"2013","unstructured":"de Bartolomeis A, Balletta R, Giordano S, Buonaguro EF, Latte G, Iasevoli F. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses. Psychiatry Res. 2013;210:387\u201395.","journal-title":"Psychiatry Res"},{"key":"3806_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.psychres.2015.11.028","volume":"235","author":"D Frydecka","year":"2016","unstructured":"Frydecka D, Besz\u0142ej JA, Go\u015bcimski P, Kiejna A, Misiak B. Profiling cognitive impairment in treatment-resistant schizophrenia patients. Psychiatry Res. 2016;235:133\u20138.","journal-title":"Psychiatry Res"},{"key":"3806_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2204-6","volume":"19","author":"A-S Lin","year":"2019","unstructured":"Lin A-S, Chan H-Y, Peng Y-C, Chen WJ. Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study. BMC Psychiatry. 2019;19:220.","journal-title":"BMC Psychiatry"},{"key":"3806_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","volume":"209","author":"D Siskind","year":"2016","unstructured":"Siskind D, McCartney L, Goldschlager R, Kisely S. Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2016;209:385\u201392.","journal-title":"Br J Psychiatry"},{"key":"3806_CR8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1176\/ajp.156.7.990","volume":"156","author":"K Wahlbeck","year":"1999","unstructured":"Wahlbeck K, Cheine M, Essali A, Adams C. Evidence of Clozapine\u2019s effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry. 1999;156:990\u20139.","journal-title":"Am J Psychiatry"},{"key":"3806_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00406-019-01053-6","volume":"270","author":"P Shah","year":"2020","unstructured":"Shah P, Iwata Y, Brown EE, Kim J, Sanches M, Takeuchi H, et al. Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study. Eur Arch Psychiatry Clin Neurosci. 2020;270:11\u201322.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3806_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00002826-200601000-00009","volume":"29","author":"F Mouaffak","year":"2006","unstructured":"Mouaffak F, Tranulis C, Gourevitch R, Poirier M-F, Douki S, Oli\u00e9 J-P, et al. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia. Clin Neuropharmacol. 2006;29:28\u201333.","journal-title":"Clin Neuropharmacol"},{"key":"3806_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1177\/0706743717718167","volume":"62","author":"D Siskind","year":"2017","unstructured":"Siskind D, Siskind V, Kisely S. Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis. Can J Psychiatry. 2017;62:772\u20137.","journal-title":"Can J Psychiatry"},{"key":"3806_CR12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","volume":"60","author":"PF Sullivan","year":"2003","unstructured":"Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187\u201392.","journal-title":"Arch Gen Psychiatry"},{"key":"3806_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng.3725","volume":"49","author":"CR Marshall","year":"2017","unstructured":"Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2017;49:27\u201335.","journal-title":"Nat Genet"},{"key":"3806_CR14","doi-asserted-by":"publisher","first-page":"e2112560118","DOI":"10.1073\/pnas.2112560118","volume":"118","author":"AW Zoghbi","year":"2021","unstructured":"Zoghbi AW, Dhindsa RS, Goldberg TE, Mehralizade A, Motelow JE, Wang X, et al. High-impact rare genetic variants in severe schizophrenia. Proc Natl Acad Sci USA. 2021;118:e2112560118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3806_CR15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy V, Pardi\u00f1as AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502\u20138.","journal-title":"Nature"},{"key":"3806_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","volume":"604","author":"T Singh","year":"2022","unstructured":"Singh T, Poterba T, Curtis D, Akil H, Al Eissa M, Barchas JD, et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 2022;604:509\u201316.","journal-title":"Nature"},{"key":"3806_CR17","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1038\/s41380-023-02293-8","volume":"28","author":"MJ Owen","year":"2023","unstructured":"Owen MJ, Legge SE, Rees E, Walters JTR, O\u2019Donovan MC. Genomic findings in schizophrenia and their implications. Mol Psychiatry. 2023;28:3638\u201347.","journal-title":"Mol Psychiatry"},{"key":"3806_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41583-024-00837-7","volume":"25","author":"PF Sullivan","year":"2024","unstructured":"Sullivan PF, Yao S, Hjerling-Leffler J. Schizophrenia genomics: genetic complexity and functional insights. Nat Rev Neurosci. 2024;25:611\u201324.","journal-title":"Nat Rev Neurosci"},{"key":"3806_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/schbul\/sbac175","volume":"49","author":"M Farrell","year":"2023","unstructured":"Farrell M, Dietterich TE, Harner MK, Bruno LM, Filmyer DM, Shaughnessy RA, et al. Increased prevalence of rare copy number variants in treatment-resistant psychosis. Schizophr Bull. 2023;49:881\u201392.","journal-title":"Schizophr Bull"},{"key":"3806_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1001\/jamapsychiatry.2021.3799","volume":"79","author":"AF Pardi\u00f1as","year":"2022","unstructured":"Pardi\u00f1as AF, Smart SE, Willcocks IR, Holmans PA, Dennison CA, Lynham AJ, et al. Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia. JAMA Psychiatry. 2022;79:260.","journal-title":"JAMA Psychiatry"},{"key":"3806_CR21","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1038\/s41380-020-00984-0","volume":"26","author":"CC Clements","year":"2021","unstructured":"Clements CC, Karlsson R, Lu Y, Jur\u00e9us A, R\u00fcck C, Andersson E, et al. Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy. Mol Psychiatry. 2021;26:2429\u201339.","journal-title":"Mol Psychiatry"},{"key":"3806_CR22","doi-asserted-by":"publisher","first-page":"sgaf019","DOI":"10.1093\/schizbullopen\/sgaf019","volume":"6","author":"RC Josiassen","year":"2025","unstructured":"Josiassen RC, Xavier RM, Dietterich TE, Harner MK, Filmyer DM, Houpt C, et al. Obstacles, opportunities, and ethical considerations for genomic investigations of individuals continuously hospitalized with treatment-resistant schizophrenia. Schizophr Bull Open. 2025;6:sgaf019.","journal-title":"Schizophr Bull Open"},{"key":"3806_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1176\/appi.ajp.2007.07101573","volume":"165","author":"AR Sanders","year":"2008","unstructured":"Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry. 2008;165:497\u2013506.","journal-title":"Am J Psychiatry"},{"key":"3806_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson JF, Almqvist C, Bonamy A-KE, Ljung R, Micha\u00eblsson K, Neovius M, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31:125\u201336.","journal-title":"Eur J Epidemiol"},{"key":"3806_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim J-L, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"key":"3806_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish prescribed drug register\u2013opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16:726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3806_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature"},{"key":"3806_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1192\/bjp.bp.113.131052","volume":"204","author":"E Rees","year":"2014","unstructured":"Rees E, Walters JTR, Georgieva L, Isles AR, Chambert KD, Richards AL, et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry. 2014;204:108\u201314.","journal-title":"Br J Psychiatry"},{"key":"3806_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41588-018-0059-2","volume":"50","author":"AF Pardi\u00f1as","year":"2018","unstructured":"Pardi\u00f1as AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50:381\u20139.","journal-title":"Nat Genet"},{"key":"3806_CR30","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/ng.2742","volume":"45","author":"S Ripke","year":"2013","unstructured":"Ripke S, O\u2019Dushlaine C, Chambert K, Moran JL, K\u00e4hler AK, Akterin S, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45:1150\u20139.","journal-title":"Nat Genet"},{"key":"3806_CR31","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1017\/S0033291706008385","volume":"36","author":"P Lichtenstein","year":"2006","unstructured":"Lichtenstein P, Bj\u00f6rk C, Hultman CM, Scolnick E, Sklar P, Sullivan PF. Recurrence risks for schizophrenia in a Swedish National Cohort. Psychol Med. 2006;36:1417\u201325.","journal-title":"Psychol Med"},{"key":"3806_CR32","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","volume":"48","author":"S McCarthy","year":"2016","unstructured":"McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48:1279\u201383.","journal-title":"Nat Genet"},{"key":"3806_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","volume":"590","author":"D Taliun","year":"2021","unstructured":"Taliun D, Harris DN, Kessler MD, Carlson J, Szpiech ZA, Torres R, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program. Nature. 2021;590:290\u20139.","journal-title":"Nature"},{"key":"3806_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51:584\u201391.","journal-title":"Nat Genet"},{"key":"3806_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"3806_CR36","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41588-018-0152-6","volume":"50","author":"JE Savage","year":"2018","unstructured":"Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018;50:912\u20139.","journal-title":"Nat Genet"},{"key":"3806_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12653-0","volume":"10","author":"LR Lloyd-Jones","year":"2019","unstructured":"Lloyd-Jones LR, Zeng J, Sidorenko J, Yengo L, Moser G, Kemper KE, et al. Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat Commun. 2019;10:5086.","journal-title":"Nat Commun"},{"key":"3806_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.","journal-title":"Gigascience"},{"key":"3806_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-2-13","volume":"2","author":"J McGrath","year":"2004","unstructured":"McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004;2:13.","journal-title":"BMC Med"},{"key":"3806_CR40","unstructured":"Shaun Purcell CC. PLINK2. www.Cog-Genomics.Org\/Plink\/20\/."},{"key":"3806_CR41","unstructured":"R Core Team R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2025. https:\/\/www.R-project.org\/."},{"key":"3806_CR42","unstructured":"Posit team RStudio: Integrated Development Environment for R. Posit Software, PBC, Boston, MA. 2025. URL http:\/\/www.posit.co\/."},{"key":"3806_CR43","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41582-020-0364-0","volume":"16","author":"OB Smeland","year":"2020","unstructured":"Smeland OB, Frei O, Dale AM, Andreassen OA. The polygenic architecture of schizophrenia \u2014 rethinking pathogenesis and nosology. Nat Rev Neurol. 2020;16:366\u201379.","journal-title":"Nat Rev Neurol"},{"key":"3806_CR44","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1038\/s41380-019-0575-1","volume":"26","author":"K Kowalec","year":"2021","unstructured":"Kowalec K, Lu Y, Sariaslan A, Song J, Ploner A, Dalman C, et al. Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study. Mol Psychiatry. 2021;26:4487\u201395.","journal-title":"Mol Psychiatry"},{"key":"3806_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01649-4","volume":"11","author":"E Koch","year":"2021","unstructured":"Koch E, Nyberg L, Lundquist A, Pudas S, Adolfsson R, Kauppi K. Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals. Transl Psychiatry. 2021;11:520.","journal-title":"Transl Psychiatry"},{"key":"3806_CR46","doi-asserted-by":"publisher","first-page":"112506","DOI":"10.1016\/j.psychres.2019.112506","volume":"280","author":"S Alberich","year":"2019","unstructured":"Alberich S, Fern\u00e1ndez-Sevillano J, Gonz\u00e1lez-Ortega I, Usall J, S\u00e1enz M, Gonz\u00e1lez-Fraile E, et al. A systematic review of sex-based differences in effectiveness and adverse effects of clozapine. Psychiatry Res. 2019;280:112506.","journal-title":"Psychiatry Res"},{"key":"3806_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/women1020009","volume":"1","author":"L Fonseca","year":"2021","unstructured":"Fonseca L, Machado V, Luersen YC, Paraventi F, Doretto L, Chaves AC. Sex selection bias in schizophrenia antipsychotic trials\u2014an update systematic review. Women. 2021;1:97\u2013108.","journal-title":"Women"},{"key":"3806_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.schres.2021.05.006","volume":"232","author":"E Wellesley Wesley","year":"2021","unstructured":"Wellesley Wesley E, Patel I, Kadra-Scalzo G, Pritchard M, Shetty H, Broadbent M, et al. Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register. Schizophr Res. 2021;232:68\u201376.","journal-title":"Schizophr Res"},{"key":"3806_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-015-0075-x","volume":"14","author":"SG Anderson","year":"2015","unstructured":"Anderson SG, Livingston M, Couchman L, Smith DJ, Connolly M, Miller J, et al. Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey. Ann Gen Psychiatry. 2015;14:39.","journal-title":"Ann Gen Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03806-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03806-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03806-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:20:16Z","timestamp":1785842416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03806-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":49,"alternative-id":["3806"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03806-x","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PFS reports potentially competing financial interests: Lundbeck (grant recipient) and Neumora Therapeutics (advisory committee, shareholder). JTRW and MOD have received grant funding from Takeda Pharmaceuticals and Akrivia Health for work unrelated to the current research.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}